Manfredi Rizzo is former Director, Clinical Medical & Regulatory Department, Novo Nordisk Europe East and South and has given lectures, received honoraria and research support, and participated in conferences, advisory boards and clinical trials sponsored by pharmaceutical industry including Amgen, AstraZeneca, Boehringer Ingelheim, Kowa, Eli Lilly, Meda, Mylan, Merck Sharp & Dohme, Novo Nordisk, Novartis, Roche Diagnostics, Sanofi and Servier
Rapid weight loss isnt just about losing fatit also leads to muscle loss
Explore these proven ways to optimize your natural glp1 and take meaningful steps toward improved health and weight management.
When the sharps container is full, dispose of it at an authorized collection center
Titrate the dosage of the new medication according to its FDA-approved dosing schedule in partnership with your healthcare provider
What are the benefits of semaglutide injections